(9-484) Intravenous Ondansetron versus Palonosetron for Prevention of Delayed Chemotherapy Induced Nausea and Vomiting for Moderately Emetogenic Chemotherapy Regimens
Wednesday, December 10, 2025
8:30 AM - 9:30 AM
Location: Bayside A, Level 1
Residency Program: Tallahassee Memorial HealthCare Residency Program Type: PGY1 & PGY2 Combined (PGY1 Pharmacy & PGY2 Health System Pharmacy Administration and Leadership) Residency Program Location: Florida
